Review

Published on 17 Jul 2024

Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022

in Renal Pharmacology

Wenchao Xu
Zitong Chen
Yurong Zhang
Jiayu Zhao
Wenyong Huang
Xiao Guo
Jianyu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388641

1,108 views

Original Research

Published on 15 Jul 2024

Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury

in Renal Pharmacology

Xinyao Luo
Weijian Zhou
Dingyuan Wan
Jing Peng
Ruoxi Liao
Baihai Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409654

1,090 views

Review

Published on 10 Jul 2024

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis

in Renal Pharmacology

Song Ren
Yurong Zhao
Jingyu Wu
Shangqing Ren
Yunlin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406588

1,175 views

Original Research

Published on 09 Jul 2024

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway

in Renal Pharmacology

Jie Qu
Hui Pei
Xin-Ze Li
Yan Li
Jian-Ming Chen
Min Zhang
Zhong-Qiu Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414918

1,345 views
1 citation

Original Research

Published on 04 Jul 2024

De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease

in Renal Pharmacology

Maxime Pluquet
Marie Metzger
Christian Jacquelinet
Christian Combe
Denis Fouque
Maurice Laville
Luc Frimat
Ziad A. Massy
Sophie Liabeuf
Solène M. Laville

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375838

1,018 views

Original Research

Published on 01 Jul 2024

Bibliometric and visual analysis of immunisation associated with acute kidney injury from 2003 to 2023

in Renal Pharmacology

Ling Chen
Jing Hu
Jianrao Lu
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388527

1,371 views

Original Research

Published on 28 Jun 2024

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

in Renal Pharmacology

David A. Vesey
Abishek Iyer
Evan Owen
Danielle Kamato
David W. Johnson
Glenda C. Gobe
David P. Fairlie
David J. Nikolic-Paterson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382094

1,050 views

Systematic Review

Published on 25 Jun 2024

Influence of sodium/glucose cotransporter-2 inhibitors on the incidence of acute kidney injury: a meta-analysis

in Renal Pharmacology

Qian Wang
Jianmin Yu
Weizhu Deng
Chao Liu
Jian Yang
Yaqing Li
Guangyan Cai
Xiangmei Chen
Zheyi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372421

1,073 views

Original Research

Published on 21 Jun 2024

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system

in Renal Pharmacology

Jingyi Zhang
Yuting Guo
Chunyan Wei
Yu Yan
Huifang Shan
Bin Wu
Fengbo Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363501

1,358 views
1 citation

Original Research

Published on 19 Jun 2024

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

in Renal Pharmacology

Xiangmeng Li
Shimin Jiang
Xia Gu
Xiaojing Liu
Shunlai Shang
Jiao Zhang
Keying Pang
Wenge Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380326

1,347 views

Original Research

Published on 12 Jun 2024

SGLT2i treatment during AKI and its association with major adverse kidney events

in Renal Pharmacology

Luz Alcantar-Vallin
Jose J. Zaragoza
Bladimir Díaz-Villavicencio
Karla Hernandez-Morales
Jahir R. Camacho-Guerrero
Miguel A. Perez-Venegas
Edgar J. Carmona-Morales
Alexa N. Oseguera-Gonzalez
Cesar Murguia-Soto
Gael Chávez-Alonso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356991

1,997 views

Original Research

Published on 10 Jun 2024

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

in Renal Pharmacology

Jian-Chun Li
Shi-Tao Huang
Fei Feng
Lin-Jun Wang
Ting-Ting Chen
Min Li
Li-Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389354

1,697 views

Review

Published on 07 Jun 2024

Targeting pyruvate kinase M2 for the treatment of kidney disease

in Renal Pharmacology

Dan-Qian Chen
Jin Han
Hui Liu
Kai Feng
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376252

2,232 views

Original Research

Published on 07 Jun 2024

Myricitrin inhibited ferritinophagy-mediated ferroptosis in cisplatin-induced human renal tubular epithelial cell injury

in Renal Pharmacology

Jiawen Lin
Yangyang Zhang
Hui Guan
Shuping Li
Yuan Sui
Ling Hong
Zhihua Zheng
Mingcheng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372094

1,437 views

Systematic Review

Published on 30 May 2024

Pooled-analysis of tadalafil and tamsulosin for ureteral calculi

in Renal Pharmacology

Fengze Sun
Hongquan Liu
Gang Wu
Ming Liu
Shangjing Liu
Lin Wang
Qingsong Zou
Yuanshan Cui
Jitao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1351312

1,237 views

Original Research

Published on 30 May 2024

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis

in Renal Pharmacology

Emiko Otsuka
Mineaki Kitamura
Satoshi Funakoshi
Hiroshi Mukae
Tomoya Nishino

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362242

1,542 views

Navigation group

Articles

Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022

Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway

De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease

Bibliometric and visual analysis of immunisation associated with acute kidney injury from 2003 to 2023

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

Influence of sodium/glucose cotransporter-2 inhibitors on the incidence of acute kidney injury: a meta-analysis

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

SGLT2i treatment during AKI and its association with major adverse kidney events

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

Targeting pyruvate kinase M2 for the treatment of kidney disease

Myricitrin inhibited ferritinophagy-mediated ferroptosis in cisplatin-induced human renal tubular epithelial cell injury

Pooled-analysis of tadalafil and tamsulosin for ureteral calculi

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis